View All News

Lygos Closes Series B Financing

We are excited to announce the close of Lygos’ $15.5MM Series B round of financing. Led by IA Ventures and First Round Capital, these funds will be used to accelerate commercialization of our pipelined products and expand our technology platform. Having successfully developed a bio-based route to malonates, we now look forward to bringing new aspartic, glycolic, and lactic acid technologies to market, among others.

Read more:

Lygos Raises $15.5 Million to Accelerate Delivery of Clean and Sustainable Biology-Based Performance Materials. Globe Newswire (July 2018)

More News
May 7, 2019
Lygos Appoints Photon Rao as Chief Patent Counsel
April 16, 2019
Lygos Appoints Bryce Dille as Vice President of Finance
March 11, 2019
Lygos Awarded Three Innovation Research Grants to Advance Applications for its Portfolio of Sustainable Specialty Biochemicals